Integrating Tobacco Treatment into Cancer Care

Protocol
14-079
Full Title
Integrating Tobacco Use Treatment Into Cancer Care
Disease Status
Newly Diagnosed & Relapsed/Refractory
Purpose

The purpose of this study is to compare two smoking cessation treatments in smokers who are receiving treatment at Memorial Sloan Kettering Cancer Center. One treatment approach includes our current standard of smoking cessation counseling. The second approach involves intensive smoking cessation counseling and includes additional counseling sessions, such as those focusing on smoking relapse and support after cancer treatment.

Participants in both groups will be offered the opportunity to use smoking cessation medications, such as varenicline or nicotine replacement. Those who are in the standard care group will pay for these medications themselves, while those in the intensive treatment group who choose to take these medications will receive them free of charge. Participants should plan to be in the study for about six months.

Eligibility

This study includes patients (age 18 and older) receiving care at Memorial Sloan Kettering Cancer Center who smoke and are interested in quitting.

For more information about this study, please contact Dr. Jamie Ostroff at 646-888-0041.

Disease(s)
Tobacco Cessation
Locations

Cancer Clinical Trials: Personalizing for Each Patient

Join our experts for a discussion of clinical trials on November 18. Clinical trials can give patients access to new drugs and other treatments before they are widely available, but how do you know if a trial is right for you?

Learn more »